List of insiders holdings for CURIS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Aurigene Discovery Technologies Ltd DR REDDYS LABORATORIES LTD Dr. Reddy's Holdings Ltd 10% Owner | 2016-09-13 13:26:11 | 27,328,464 0 | 27,328,464 | Form 13G |
| Dentzer James E President & CEO | 2023-01-24 16:05:04 | 1,000,000 0 | 1,000,000 | Form 4 |
| MCNAB JAMES R Director | 2017-05-05 17:34:09 | 879,688 50,000 | 929,688 | Form 4/A |
| Fattaey Ali Ph.D. President & CEO | 2018-05-17 16:08:25 | 825,000 0 | 825,000 | Form 4 |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC Indirect Beneficial Owner 10% Owner | 2021-02-11 16:43:23 | 626,945 0 | 626,945 | Form 13G |
| Tuck David Chief Medical Officer | 2018-05-17 16:11:44 | 535,000 0 | 535,000 | Form 4 |
| Zung Jonathan B. CDO | 2023-05-03 16:12:06 | 500,000 0 | 500,000 | Form 4 |
| Duvall Diantha CFO | 2023-01-24 16:10:35 | 500,000 0 | 500,000 | Form 4 |
| Mohindru Mani Chief Strategy Officer | 2017-02-16 16:36:38 | 424,000 0 | 424,000 | Form 4 |
| Steinkrauss William Chief Financial Officer | 2022-01-31 17:17:42 | 360,000 0 | 360,000 | Form 4 |
| Martell Robert Head of Research & Development | 2023-01-24 16:09:17 | 350,000 0 | 350,000 | Form 4 |
| MELTON DOUGLAS Director | 2006-08-24 10:30:08 | 163,499 0 | 163,499 | Form 4/A |
| Qian Changgeng VP, Research & Preclinical Dev | 2011-01-10 15:58:13 | 125,000 0 | 125,000 | Form 4 |
| Voi Maurizio Chief Medical Officer | 2013-01-18 16:19:26 | 125,000 0 | 125,000 | Form 4 |
| Pienta Kenneth Director | 2017-03-02 16:56:26 | 120,000 0 | 120,000 | Form 4 |
| MISSLING CHRISTOPHER U Sr. VP, Strategic Planning | 2004-01-21 17:22:53 | 104,600 0 | 104,600 | Form 4 |
| POTTHOFF MARY ELIZABETH VP and General Counsel | 2006-06-02 15:45:40 | 102,706 0 | 102,706 | Form 4 |
| RUBIN LEE L VP of Research | 2005-06-03 15:11:41 | 100,000 0 | 100,000 | Form 4 |
| KAITIN KENNETH I Director | 2023-01-24 16:16:48 | 85,000 0 | 85,000 | Form 4 |
| Hohneker John Director | 2023-01-24 16:15:36 | 85,000 0 | 85,000 | Form 4 |
| Rubin Marc Director | 2023-01-24 16:14:18 | 85,000 0 | 85,000 | Form 4 |
| GREENACRE MARTYN D Director | 2023-01-24 16:13:25 | 85,000 0 | 85,000 | Form 4 |
| Borgman Anne Elizabeth Director | 2023-01-24 16:12:13 | 85,000 0 | 85,000 | Form 4 |
| Kunkel Lori Anne Director | 2022-01-31 17:33:15 | 85,000 0 | 85,000 | Form 4 |
| GRAY MICHAEL CFO | 2015-05-28 16:05:58 | 80,000 0 | 80,000 | Form 4 |
| Viner Jaye Chief Medical Officer | 2015-05-28 16:06:39 | 80,000 0 | 80,000 | Form 4 |
| Keegan Mitchell Vice-President | 2011-01-10 15:57:19 | 60,000 0 | 60,000 | Form 4 |
| PASSERI DANIEL R Director | 2016-01-21 16:20:38 | 50,000 0 | 50,000 | Form 4 |
| DAVIE JOSEPH M Director | 2007-06-08 14:06:49 | 35,000 0 | 35,000 | Form 4 |
| NOEL MARK VP, Tech Management | 2013-05-03 16:16:04 | 27,540 0 | 27,540 | Form 4 |
| DAVIE JOSEPH MD PHD Director | 2011-01-10 16:00:26 | 25,000 0 | 25,000 | Form 4 |
| BAYH SUSAN B Director | 2013-01-18 16:20:00 | 25,000 0 | 25,000 | Form 4 |
| TOBIN JAMES R Director | 2015-01-28 16:25:03 | 25,000 0 | 25,000 | Form 4 |
| CARTER STEPHEN Director | 2008-01-28 15:13:17 | 15,000 0 | 15,000 | Form 4 |
| KUNATH RUTH B Director | 2003-06-16 14:14:25 | 5000 0 | 5000 | Form 4 |
| RA CAPITAL MANAGEMENT LLC RA Capital Biotech Fund LP RA Capital Biotech Fund II L.P. ALDRICH RICHARD Kolchinsky Peter 10% Owner | 2021-11-15 16:33:53 | 0 0 | 0 | Form 13G |